search
Back to results

Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections

Primary Purpose

Urinary Tract Infections

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
SpeediCath
Conveen Uncoated
Sponsored by
Coloplast A/S
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Urinary Tract Infections

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Traumatic spinal cord injury within 3 months prior to inclusion Neurogenic bladder dysfunction requiring intermittent catheterization at least 3 times daily Exclusion Criteria: Has symptoms of UTI at inclusion Treated with prophylactic antibiotics to prevent UTIs Has a history of unresolved bladder-ureteral reflux and/or stones in the urinary tract Has used intermittent catheterization for more than 10 days prior to inclusion

Sites / Locations

  • Rancho Los Amigos National Rehabilitation Center
  • Santa Clara Valley Medical Center
  • Craig Hospital
  • University of Miami
  • Shepherd Center
  • Boston Medical School
  • University of Michigan Helaths Systems
  • Mayo Clinic, Saint Mary Hospital MB3CF Rehabilitation
  • Kessler Institute for Rehabilitation
  • Mount Sinai School of Medicine
  • Carolinas Medical Center
  • The Institute for Rehabilitation and Research (TIRR)
  • University of Alberta
  • G.F.Strong Rehabilitation Centre
  • Parkwood Rehabilitation Centre
  • Toronto Rehabilitation Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

SpeediCath

Conveen Uncoated

Arm Description

hydrophilic-coated intermittent catheter

uncoated urinary intermittent catheter

Outcomes

Primary Outcome Measures

Occurrence of Symptomatic Urinary Tract Infections (UTIs)
Occurrence of symptomatic urinary tract infections (UTIs). Time to first UTI

Secondary Outcome Measures

UTIs With Bacteriuria >=100 Colony Forming Units (CFU)/ml
UTIs with bacteriuria >=100 Colony Forming Units (CFU)/ml. Descriptive analysis
Nurse Evaluation of Catheters - Overall Satisfaction
Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)
Patient or Caregiver's Evaluation of Catheters - Overall Satisfaction
Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)
Nurse Time Spent on Catheterization Procedure
Device-related or Possibly Device-related AEs
Number of Participants With One or More Urinary Tract Infection

Full Information

First Posted
April 26, 2006
Last Updated
January 26, 2021
Sponsor
Coloplast A/S
search

1. Study Identification

Unique Protocol Identification Number
NCT00318591
Brief Title
Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections
Official Title
A Prospective, Randomized, Parallel-group, Multi-center Study to Compare the Occurrence of Urinary Tract Infections in Patients With Spinal Cord Injury Using Either Coated or Uncoated Intermittent Catheters.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2015
Overall Recruitment Status
Completed
Study Start Date
April 2006 (undefined)
Primary Completion Date
October 2009 (Actual)
Study Completion Date
October 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coloplast A/S

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to investigate the frequency of urinary tract infections with symptoms in spinal cord injured patients requiring intermittent catheterization for emptying the bladder. Patients will use either a coated catheter or an uncoated catheter with gel.
Detailed Description
Introduction: Spinal cord injured (SCI) constitutes a large group of patients suffering from neurogenic bladder dysfunction, which is often managed by intermittent catheterization (IC). Intermittent catheterization is accepted as a safe and effective method for maintaining bladder and renal health in individuals with neurogenic bladder dysfunction. However, IC several times a day places an individual at risk for urethral trauma, hematuria, and particularly symptomatic urinary tract infections (UTI). Attempts to control UTI with prophylactic antibiotics or sterile technique have not been overly successful but more recent advances in catheter technology, such as the hydrophilic-coated catheter, offer potential benefit. The hydrophilic-coated catheter has a slippery, pre-lubricated surface (along the entire length of the catheter) when soaked in water, allowing smooth insertion without the need for additional water soluble lubricant. Two proposed advantages over uncoated catheters are 1) reduced incidence of symptomatic UTI, and 2) reduction of urethral irritation or urethral trauma, and lowered risk of urethral strictures. Currently, while there are trends in favour of hydrophilic-coated catheters with respect to UTI overall evidence remains inadequate for clinical decision-making for choice of catheter type. Randomised trials to date have been limited by short follow up, heterogeneity, attrition, imprecise outcome measures, and varying definitions of UTI5. Conclusions of the Cochrane group in 20076 were echoed in a recent comprehensive re-view of all studies on hydrophilic-coated catheters - there is modest evidence favouring hydrophilic-coated catheter in reduction of UTI, but further robust research is required.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Tract Infections

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
219 (Actual)

8. Arms, Groups, and Interventions

Arm Title
SpeediCath
Arm Type
Experimental
Arm Description
hydrophilic-coated intermittent catheter
Arm Title
Conveen Uncoated
Arm Type
Experimental
Arm Description
uncoated urinary intermittent catheter
Intervention Type
Device
Intervention Name(s)
SpeediCath
Other Intervention Name(s)
Coated Catheter
Intervention Description
hydrophilic coated urinary intermittent catheter
Intervention Type
Device
Intervention Name(s)
Conveen Uncoated
Other Intervention Name(s)
Uncoated catheter
Intervention Description
Uncoated urinary intermittent catheter
Primary Outcome Measure Information:
Title
Occurrence of Symptomatic Urinary Tract Infections (UTIs)
Description
Occurrence of symptomatic urinary tract infections (UTIs). Time to first UTI
Time Frame
4-6 months
Secondary Outcome Measure Information:
Title
UTIs With Bacteriuria >=100 Colony Forming Units (CFU)/ml
Description
UTIs with bacteriuria >=100 Colony Forming Units (CFU)/ml. Descriptive analysis
Time Frame
4-6 months
Title
Nurse Evaluation of Catheters - Overall Satisfaction
Description
Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)
Time Frame
4-6 months
Title
Patient or Caregiver's Evaluation of Catheters - Overall Satisfaction
Description
Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)
Time Frame
4-6 months
Title
Nurse Time Spent on Catheterization Procedure
Time Frame
4-6 months
Title
Device-related or Possibly Device-related AEs
Time Frame
4-6 months
Title
Number of Participants With One or More Urinary Tract Infection
Time Frame
4-6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Traumatic spinal cord injury within 3 months prior to inclusion Neurogenic bladder dysfunction requiring intermittent catheterization at least 3 times daily Exclusion Criteria: Has symptoms of UTI at inclusion Treated with prophylactic antibiotics to prevent UTIs Has a history of unresolved bladder-ureteral reflux and/or stones in the urinary tract Has used intermittent catheterization for more than 10 days prior to inclusion
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Diana Cardenas, MD
Organizational Affiliation
University of Miami
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rancho Los Amigos National Rehabilitation Center
City
Downey
State/Province
California
ZIP/Postal Code
90242
Country
United States
Facility Name
Santa Clara Valley Medical Center
City
San Jose
State/Province
California
ZIP/Postal Code
95128
Country
United States
Facility Name
Craig Hospital
City
Englewood
State/Province
Colorado
ZIP/Postal Code
80113
Country
United States
Facility Name
University of Miami
City
Miami
State/Province
Florida
ZIP/Postal Code
33101
Country
United States
Facility Name
Shepherd Center
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30309
Country
United States
Facility Name
Boston Medical School
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02188
Country
United States
Facility Name
University of Michigan Helaths Systems
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48108
Country
United States
Facility Name
Mayo Clinic, Saint Mary Hospital MB3CF Rehabilitation
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55902
Country
United States
Facility Name
Kessler Institute for Rehabilitation
City
West Orange
State/Province
New Jersey
ZIP/Postal Code
07052
Country
United States
Facility Name
Mount Sinai School of Medicine
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
Facility Name
Carolinas Medical Center
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28303
Country
United States
Facility Name
The Institute for Rehabilitation and Research (TIRR)
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
University of Alberta
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 2C8
Country
Canada
Facility Name
G.F.Strong Rehabilitation Centre
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V5Z 2G9
Country
Canada
Facility Name
Parkwood Rehabilitation Centre
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 4G5
Country
Canada
Facility Name
Toronto Rehabilitation Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4G 3V9
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections

We'll reach out to this number within 24 hrs